NCT05798442Not yet recruiting
The Impact of Using a Smartphone Health Application in the Improvement of Cardiovascular Disease Risk Factors
The Impact of Using a Smartphone Health Application in the Improvement of Cardiovascular Disease Risk Factors in the Omani Population; Prospective Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 4 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study investigates the effectiveness of Mobile health application (mHealth apps) in the improvement of cardiovascular disease risk factors including metabolic and behavioral factors. The app will be tested on patients with any of the modifiable risk factors of CVD such as hypertension, obesity, hyperlipidemia, and impaired glycemic control/type 2 diabetes mellitus .
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 410 (estimated)
- First submitted
- 12 Mar 2023
- Start date
- 30 Jan 2024
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Sultan Qaboos University
- NCT number
- NCT05798442
What you commit to
- Study type: Interventional
- Planned participants: 410
- From 30 Jan 2024 to the primary completion date, 30 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A history of stroke, myocardial infarction or any related cardiovascular complications Complicated diabetes mellitus e.g., Proliferative diabetic retinopathy, end-stage renal disease
- Medical conditions that restrain the participant to be physically active.
Other
- Unavailability of a smartphone or any reason that will not allow the participant to use the app properly. (such as; difficulty or inability to use mobile applications, unavailability of network services…etc.).
- High chance of loss to follow up at the FAMCO clinic (due to upcoming travel, temporary employment and thus eligibility to be treated at the clinic, irregular visits due to distance from home…etc.)
Who the study is looking for
- Presentation with at least one of the following metabolic abnormalities:
- Hypertensions (systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg)
- Obesity (waist circumference ≥ 80 cm (women) or ≥ 94 cm (men) and BMI ≥ 25 kg/m2)
- Dyslipidemia (triglycerides ≥ 1.7 mmol/L or/and HDL-cholesterol ≤ 1.29 mmol/L (women) or ≤ 1.02 mmol/L (men) or/and LDL-Cholesterol \> 5.18 mmol/L, serum total cholesterol ≥ 5.2 mmol/l)
- Impaired glycemia/type 2 diabetes (fasting plasma glucose ≥ 5.6 mmol/L)
- Arabic or English language speaking and able to read and write in one of these languages
- Possession of a smart mobile phone Willing to utilize a mobile application for CVD management.
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.